» Articles » PMID: 37341161

Pharmacokinetic Pharmacodynamic Modeling of Analgesics and Sedatives in Children

Overview
Date 2023 Jun 21
PMID 37341161
Authors
Affiliations
Soon will be listed here.
Abstract

Pharmacokinetic pharmacodynamic modeling is an important tool which uses statistical methodology to provide a better understanding of the relationship between concentration and effect of drugs such as analgesics and sedatives. Pharmacokinetic pharmacodynamic models also describe between-subject variability that allows identification of subgroups and dose adjustment for optimal pain management in individual patients. This approach is particularly useful in the pediatric population, where most drugs have received limited evaluation and dosing is extrapolated from adult practice. In children, the covariates of weight and age are used to describe size- and maturation-related changes in pharmacokinetics. It is important to consider both size and maturation in order to develop an accurate model and determine the optimal dose for different age groups. An adequate assessment of analgesic and sedative effect using pain scales or brain activity measures is essential to build reliable pharmacokinetic pharmacodynamic models. This is often challenging in children due to the multidimensional nature of pain and the limited sensitivity and specificity of some measurement tools. This review provides a summary of the pharmacokinetic and pharmacodynamic methodology used to describe the dose-concentration-effect relationship of analgesics and sedation in children, with a focus on the different pharmacodynamic endpoints and the challenges of pharmacodynamic modeling.

Citing Articles

Ciprofol as compared to propofol for sedation and general anesthesia: a systematic review of randomized controlled trials.

Curro J, Santonocito C, Merola F, Messina S, Sanfilippo M, Brancati S J Anesth Analg Crit Care. 2024; 4(1):24.

PMID: 38589912 PMC: 11000282. DOI: 10.1186/s44158-024-00159-1.


Pharmacokinetic pharmacodynamic modeling of analgesics and sedatives in children.

Bardol M, Pan S, Walker S, Standing J, Dawes J Paediatr Anaesth. 2023; 33(10):781-792.

PMID: 37341161 PMC: 10947261. DOI: 10.1111/pan.14712.

References
1.
Playne R, Anderson B, Frampton C, Stanescu I, Atkinson H . Analgesic effectiveness, pharmacokinetics, and safety of a paracetamol/ibuprofen fixed-dose combination in children undergoing adenotonsillectomy: A randomized, single-blind, parallel group trial. Paediatr Anaesth. 2018; 28(12):1087-1095. DOI: 10.1111/pan.13517. View

2.
Louizos C, Yanez J, Forrest M, Davies N . Understanding the hysteresis loop conundrum in pharmacokinetic/pharmacodynamic relationships. J Pharm Pharm Sci. 2014; 17(1):34-91. PMC: 4332569. View

3.
Yang H, Feng Y, Xu X . Pharmacokinetic and pharmacodynamic modeling for acute and chronic pain drug assessment. Expert Opin Drug Metab Toxicol. 2014; 10(2):229-48. DOI: 10.1517/17425255.2014.864636. View

4.
Germovsek E, Barker C, Sharland M, Standing J . Pharmacokinetic-Pharmacodynamic Modeling in Pediatric Drug Development, and the Importance of Standardized Scaling of Clearance. Clin Pharmacokinet. 2018; 58(1):39-52. PMC: 6325987. DOI: 10.1007/s40262-018-0659-0. View

5.
Garrido M, Habre W, Rombout F, Troconiz I . Population pharmacokinetic/pharmacodynamic modelling of the analgesic effects of tramadol in pediatrics. Pharm Res. 2006; 23(9):2014-23. DOI: 10.1007/s11095-006-9049-7. View